Exogenous surfactant and positive end-expiratory pressure in the treatment of endotoxin-induced lung injury

Critical Care Medicine

Volumn 26, Issue 8, 1998, Pages 1379-1389

  Lutz, Charles J ^a   Picone, Anthony ^a   Gatto, Louis A ^b   Paskanik, Andrew ^a   Landas, Steve ^a   Nieman, Gary F ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Acute respiratory distress syndrome; Critical illness; Endotoxemia; Lipopolysaccharide; Lungs; Neutrophil; Porcine; Positive end expiratory pressure; Pulmonary function; Pulmonary surfactant; Septic shock

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LUNG SURFACTANT EXTRACT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HISTOLOGY; LUNG ARTERY PRESSURE; LUNG COMPLIANCE; LUNG EDEMA; LUNG FUNCTION TEST; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SWINE;

EID: 0031950490     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199808000-00025     Document Type: Article

References (48)

1. Milberg JA, Davis KP, Steinberg K, et al: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273:306-309
2. Gregory T, Steinberg K, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315
3. Ashbaugh DG, Bigelow DB, Petty T, et al: Acute respiratory distress in adults. Lancet 1967; ii:319-323
4. Fein AM, Lippman M, Holzman H, et al: The risk factors, incidence and prognosis of the adult respiratory distress syndrome following septicemia. Chest 1983; 83:40-42
5. Kaplan RL, Sahn SA, Petty TL: Incidence and outcome of the respiratory distress syndrome in Gram-negative sepsis. Arch Intern Med 1979; 139: 867-869
6. Petty TL, Silvers GW, Paul G, et al: Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 1979; 75:571-574
7. Gregory T, Longmore W, Moxley M, et al: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 65:1976-1981
8. Poison U, Obertacke U, Brand M, et al: Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990; 30:19-26
9. Gross N: Altered surfactant subtypes in an experimental form of ARDS: Radiation pneumonitis. Am J Physiol 1991; 260:L302-L310
10. Tierney DF, Johnson RP: Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 1965; 20: 1253-1260
11. Seeger W, Stöhr G, Wolf H, et al: Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol 1985; 56:326-338
12. Lewis JF, Tabor B, Ikegami M, et al: Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 1993; 74:1256-1264
13. Kobayashi T, Kataoka H, Ueda T, et al: Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J Appl Physiol 1984; 57: 995-1001
14. Lewis J, Ikegami M, Jobe A, et al: Physiologic responses and distribution of aerosolized surfactant (Survanta™) in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993; 147:1364-1370
15. Lewis J, Ikegami M, Higuchi R, et al: Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J Appl Physiol 1991; 71:1270-1276
16. Zelter M, Escudier B, Hoeffel JM, et al: Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 1990; 141: 1014-1019
17. Lamm W, Albert R: Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Respir Dis 1990; 142:1279-1283
18. Anzueto A, Baughman RP, Guntupalli KK, et al: Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996; 334:1417-1421
19. Nieman GF, Gatto LA, Paskanik A, et al: Surfactant replacement in the treatment of sepsis induced adult respiratory distress syndrome (ARDS) in pigs. Crit Care Med 1996; 24:1025-1033
20. Zucker AR, Holm RA, Crawford GP, et al: PEEP is necessary for exogenous surfactant to reduce pulmonary edema in canine aspiration pneumonitis. J Appl Physiol 1992; 73:679-686
21. Froese AB, McCulloch PR, Sugiura M, et al: Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993; 148:569-577
22. Notter RH, Egan EA, Kwong MS, et al: Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age. Pediatr Res 1985; 19:569-577
23. Barry BE, Crapo JD: Application of morphometric methods to study diffuse and focal injury in the lung caused by toxic agents. Crit Rev Toxicol 1985; 14:1-32
24. Gundersen H: Notes on the estimation of the numerical density of arbitrary profiles: The edge effect. J Microsc 1977; 111:219-223
25. Harris J, Jackson F, Moxley M, et al: Effect of exogenous surfactant instillation on experimental acute lung injury. J Appl Physiol 1989; 66:1846-1851
26. Lewis J, McCaig L: Aerosolized versus instilled exogenous surfactant in a non-uniform pattern of lung injury. Am Rev Respir Dis 1993; 148:1187-1193
27. 2 in mature rabbits with lungs that contain large amounts of saline. Am Rev Respir Dis 1993; 147:1087-1090
28. Gommers D, Vilstrup C, Bos JA, et al: Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993; 21:567-574
29. Reynolds M, Wallauder K: Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Clin Pharmacol 1989; 8:559-576
30. Huang Y, Caminiti S, Fawcett T, et al: Natural surfactant and hyperoxic lung injury in primates I. Physiology and biochemistry. J Appl Physiol 1994; 76:991-1001
31. Tashiro K, Li W-Z, Yamada K, et al: Surfactant replacement reverses respiratory failure induced by intratracheal endotoxin in rats. Crit Care Med 1995; 23:149-156
32. Tashiro K, Yamada K, Li W-Z, et al: Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats. Crit Care Med 1996; 24:488-494
33. Weg J, Balk R, Tharratt S, et al: Safety and potential efficacy of an aerosolized surfactant in human sepsis induced adult respiratory distress syndrome. JAMA 1994; 272:1433-1438
34. Gregory T, Gadek J, Weiland J, et al: Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 1994; 149:A567
35. Robertson B: Surfactant inactivation and surfactant replacement in experimental models of ARDS. Acta Anaesthesiol Scand 1991; 35(Suppl95): 22-28
36. Westby S: Mechanisms of membrane damage and surfactant depletion in acute lung injury. Intensive Care Med 1986; 12:2-5
37. Picone A, Gatto LA, Nieman GF, et al: Pulmonary surfactant function following endotoxin: Effects of exogenous surfactant treatment. Shock 1996; 5: 304-310
38. Tobin MJ: Mechanical ventilation. N Engl J Med 1994; 330:1056-1061
39. Malo J, Ali J, Wood L: How does positive end-expiratory pressure reduce intrapulmonary shunt in canine pulmonary edema. J Appl Physiol 1984; 57:1002-1010
40. Katz JA, Marks JD: Inspiratory work with and without continuous positive airway pressure in patients with acute respiratory failure. Anesthesiology 1985; 63:598-607
41. Ogawa A, Brown CL, Schlueter MA, et al: Lung function, surfactant apoprotein content, and level of PEEP in prematurely delivered rabbits. J Appl Physiol 1994; 77:1840-1849
42. Thomassen MJ, Antal JM, Conners MJ, et al: Characterization of Exosurf™ (surfactant) mediated suppression of stimulated human alveolar macrophage cytokine responses. American Journal of Cell and Molecular Biology 1994; 10:399-404
43. Antal JM, Davis LT, Erzurum SC, et al: Surfactant suppresses NF-kappa B activation in human monocyte cells. American Journal of Cell and Molecular Biology 1996; 14:374-379
44. Geertsma MF, Zomerdijk TP, Nibbering PH, et al: Pulmonary surfactant inhibits monocyte bactericidal functions by altering activation of protein kinase A and C. Immunology 1994; 83:133-139
45. Woerndle S, Bartmann P: The effect of three surfactant preparations on in vitro lymphocyte functions. J Perinatol Med 1994; 22:119-128
46. Roth MD, Pinto M, Golub SH, et al: Pulmonary surfactant inhibits interleukin-2 induced proliferation and the generation of lymphokine-activated killer cells. American Journal of Cell and Molecular Biology 1993; 9:652-658
47. Geertsma MF, Teeuw WL, Nibbering PH, et al: Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma. Immunology 1994; 82:450-456
48. Kawano T, Mori S, Cybulsky M, et al: Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987; 62:27-33